Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab

被引：0
|
作者：
Christine Vestergaard Madsen
Karina Dahl Steffensen
Dorte Aalund Olsen
Marianne Waldstrøm
Maja Smerdel
Parvin Adimi
Ivan Brandslund
Anders Jakobsen
机构：
[1] Vejle Hospital,Department of Oncology
[2] Vejle Hospital,Department of Clinical Biochemistry
[3] Vejle Hospital,Department of Pathology
[4] University of Southern Denmark,Institute for Regional Health Services Research
[5] Vejle Hospital,Department of Oncology
来源：
Journal of Ovarian Research | / 5卷
关键词：
Vascular Endothelial Growth Factor; Bevacizumab; Vascular Endothelial Growth Factor Level; Serum Vascular Endothelial Growth Factor; Bevacizumab Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 20 条
  • [1] Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
    Madsen, Christine Vestergaard
    Steffensen, Karina Dahl
    Olsen, Dorte Aalund
    Waldstrom, Marianne
    Smerdel, Maja
    Adimi, Parvin
    Brandslund, Ivan
    Jakobsen, Anders
    JOURNAL OF OVARIAN RESEARCH, 2012, 5
  • [2] THE ROLE OF CIRCULATING ANGIOGENIC PLATELET-DERIVED GROWTH FACTORS (PDGF-BB plus PDGF-AA) IN KIDNEY INJURY IN PATIENTS WITH GOUT
    Medvedeva, T.
    Kushnarenko, N.
    Mishko, M.
    ATHEROSCLEROSIS, 2019, 287 : E124 - E124
  • [3] Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis
    Nissen, Lars Johan
    Cao, Renhai
    Hedlund, Eva-Maria
    Wang, Zongwei
    Zhao, Xing
    Wetterskog, Daniel
    Funa, Keiko
    Brakenhielm, Ebba
    Cao, Yihai
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (10): : 2766 - 2777
  • [4] The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab
    Smerdel, M. P.
    Steffensen, K. D.
    Waldstrom, M.
    Brandslund, I.
    Jakobsen, A.
    GYNECOLOGIC ONCOLOGY, 2010, 118 (02) : 167 - 171
  • [5] Relationship of Glucose Fluctuation, Microvascular Complications and Serum VEGF, PDGF-BB in Type 2 Diabetic Patients
    Xu, Lijuan
    Yang, Yuzhi
    Feng, Kun
    DIABETES, 2013, 62 : A613 - A614
  • [6] Increased expression of PDGF-BB predicts metastasis and poor prognosis in ovarian cancer patients
    Song, Zhiwang
    Gao, Yong
    Ye, Xiaojuan
    Zhang, Xia
    Yang, Guang
    Feng, Chan
    Lu, Yonglin
    Dong, Chunyan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (05): : 5487 - 5492
  • [7] Serum Concentration of VEGF and PDGF-AA in Patients with Active Thyroid Orbitopathy before and after Immunosuppressive Therapy
    Nowak, M.
    Marek, B.
    Karpe, J.
    Kos-Kudla, B.
    Sieminska, L.
    Kajdaniuk, D.
    Treszer, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (10) : 582 - 586
  • [8] The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer
    Inanc, Mevlude
    Sirakaya, Hatice Aslan
    Karaman, Hatice
    Bozkurt, Oktay
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (08) : 1878 - 1885
  • [9] Preoperative Serum Levels of PDGF-AB, PDGF-BB, TGF-α, EGF and ANG-2 in the Diagnosis of Endometrial Cancer
    Kozlowski, Mateusz
    Borzyszkowska, Dominika
    Mirko, Justyna
    Turon-Skrzypinska, Agnieszka
    Piotrowska, Katarzyna
    Toloczko-Grabarek, Aleksandra
    Kwiatkowski, Sebastian
    Tarnowski, Maciej
    Rotter, Iwona
    Cymbaluk-Ploska, Aneta
    CANCERS, 2023, 15 (19)
  • [10] Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: a case-control study
    Harirchian, M. H.
    Tekieh, A. H.
    Modabbernia, A.
    Aghamollaii, V.
    Tafakhori, A.
    Ghaffarpour, M.
    Sahraian, M. A.
    Naji, M.
    Yazdanbakhsh, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (02) : 241 - 247
12